Red cell distribution width, platelet distribution width, and plateletcrit as indicators of prognosis in COVID-19 patients - A single-center study

Background: COVID-19 is still present in the world, though extent varies by region and country. According to World Health Organization, there have been over 617 million confirmed cases of 13 deaths worldwide since pandemic began on March 10, 2023. Aims Objectives: This a study conducted with aim providing biomarkers predict disease progression mortality based red cell indices platelet which are commonly measured as part complete blood count (CBC). Materials Methods: A prospective was during peak second wave from 2021 June 2021. The included 540 patients who were admitted Government General Hospital, Nizamabad, had tested positive for RT-PCR. Red Blood Cell (RBC), Hematocrit (HCT), like Mean Corpuscular Volume (MCV), Hemoglobin (MCH), Haemoglobin Concentration (MCHC), Distribution width (RDW) Platelet (MPV), Width (PDW), Plateletcrit (PCT), Platelet–Large Ratio taken CBC analyzer Sysmex XN-1000 analyzed statistically. then followed up period 14 days track their outcomes. Results: In data, majority male n=334 (62%) n=280 (38%) female. 70.37% (n=380) survivors 29.63% (n=160) non-survivors. cell, such RDW-CV RDW-SD, PCT PDW significantly higher non-survivors compared P<0.05. Conclusion: Non-survivors levels RDW-CV, PCT, survivors. These parameters combination can be useful predicting at early stage forthcoming waves.